NovoTTF-200A and Temozolomide Chemoradiation for Newly Diagnosed Glioblastoma

NCT03232424 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma, Adult

Interventions

DEVICE: NovoTTF-200A
DRUG: Temozolomide
RADIATION: 3D conformal or intensity modulated radiation therapy (IMRT)

Sponsor

Hackensack Meridian Health

Collaborators

[object Object]